2m 2m 2m 2m 2m 2m 2m
EVOLUS (EOLS)
NASDAQ
$7.43+$0.62 (+9.10%)
Price as of Nov 11, 2026 7:30 PM EST- $450.7MMarket Cap
- -2.58%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
EVOLUS (EOLS)
$7.43+$0.62 (+9.10%)
EOLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.81 | ||
Change | -$0.17 (-2.44%) | ||
Open | $6.97 | ||
High | $7.00 | ||
Low | $6.63 | ||
Previous Close | $6.98 | ||
Volume | 5,816,222 | ||
30-Day Average Volume | 1,060,967 | ||
1-Week Change | -7.60% | ||
1-Month Change | -11.90% | ||
1-Year Change | -2.58% | ||
3-Year Change | -14.87% | ||
5-Year Change | -8.71% | ||
Fundamentals | |||
Shares Outstanding | 66.2M | ||
Total Assets | $283.8M | ||
Market Cap | $450.7M | ||
Enterprise Value | $565.9M | ||
Period: QTR TTM FY | |||
Revenue | $77.2M | ||
Net Income | -$12.5M | ||
Free Cash Flow | -$2.3M | ||
EBIT | -$12.2M | ||
EBITDA | -$9.8M | ||
Net Working Capital | $59.4M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -57 | ||
Enterprise Value/Revenue | 7 | ||
P/B | -12 | ||
P/E | -36 | ||
PEG | 1 | ||
Price/Free Cash Flow | -200 | ||
Price/Operating Cash Flow | -233 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue